Rui Wu

18PUBLICATIONS
22CO-AUTHORS
Disease surveillanceCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersAutoimmunityMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 18, 2026
Risk factors for infection in rheumatoid arthritis patients treated with tocilizumab: an observational study highlighting hydroxychloroquine use.

|Jul 06, 2026
Restricted cubic spline analysis of treatment duration before tocilizumab withdrawal and relapse risk in rheumatoid arthritis.

|Mar 23, 2026
CYBB-Mediated Ferroptosis Drives Podocyte Injury in Lupus Nephritis and Represents a Therapeutic Target.

Bihua Wang, Houhui Jiang, Dengfeng Wu

|Jun 13, 2025
Efficacy and Safety of Ivarmacitinib, a Selective JAK1 Inhibitor, in Patients With Active Ankylosing Spondylitis: Results From an Adaptive Seamless Phase 2/3 Trial.

Xu Liu, Liling Xu, Cheng Zhao

|Apr 10, 2025
Neutrophils in Rheumatoid Arthritis Synovium: Implications on Disease Activity and Inflammation State.

YiHan Deng, JianBin Li, Rui Wu

|May 31, 2024
CD4/CD8 Ratio: An Independent Predictor of Herpes Zoster in Patients With Autoimmune Inflammatory Rheumatic Diseases.

Peng-Cheng Liu, Yi-Lin Peng, Jian-Bin Li

Pageof 3

Frequent Collaborators

4 joint publications

Jiangbiao Xiong

4 joint publications

Jianbin Li

3 joint publications

Shujiao Yu

3 joint publications

Peng-Cheng Liu